MERRIMACK PHARMACEUTICALS IN (MACK)

US5903282094 - Common Stock

14.74  +0.01 (+0.07%)

After market: 14.74 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
N/AN/AN/AN/AN/A
Operating Expenses
2.18M2.10M2.60M4.90M22.50M
Research and Development
N/AN/AN/A0.009.10M
Selling, General, and Administrative Expenses
2.18M2.20M2.60M4.90M13.40M
Operating Income
-2.18M-2.10M-2.60M-4.90M-22.50M
Interest Income/Expense
868.00K200.00K0.00100.00K-800.00K
Other Income/Expense
N/AN/A0.00-200.00K400.00K
Non Recurring Items
139.00K400.00K100.00K2.00M100.00K
Income Before Taxes
-1.17M-1.50M-2.50M-3.00M-22.70M
Income Tax
12.00K0.000.000.00-1.50M
Net Income
-1.18M-1.50M-2.50M-3.00M-17.30M
EBITDA
N/AN/AN/AN/A-20.27M
 
Per Share Data
EPS Diluted Total Ops
-0.08-0.11-0.18-0.23-1.29
Non GAAP EPS
N/AN/AN/AN/AN/A
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts